ACE inhibitors and angiotension II receptor blockers (ARBs) appear to reduce the risk of cardiovascular death, myocardial infarction, and stroke in patients at high cardiovascular risk but without heart failure, according to Italian research. When compared with placebo, ACE inhibitors and ARBs had odds ratios of 0.830 and 0.920, respectively, for risk of these outcomes.

Abstract: Journal of the American College of Cardiology, January 15, 2013.